Novartis Ag (NVS) Net Income towards Common Stockholders Growth (5y) (2014 - 2025)

Novartis Ag (NVS) Net Income towards Common Stockholders Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2025 14.64%
Jun 30, 2024 -3.92%
Dec 31, 2023 56.23%
Sep 30, 2023 24.31%
Jun 30, 2023 2.83%
Mar 31, 2023 19.95%
Dec 31, 2022 -21.70%
Sep 30, 2022 -16.03%
Jun 30, 2022 -2.48%
Mar 31, 2022 2.61%
Dec 31, 2021 -5.01%
Sep 30, 2021 3.99%
Jun 30, 2021 44.32%
Mar 31, 2021 22.68%
Dec 31, 2020 376.42%
Sep 30, 2020 48.73%
Jun 30, 2020 4,076.73%
Mar 31, 2020 1,201.75%
Jun 30, 2019 3,108.32%
Mar 31, 2019 -1,044.65%